AU623805B2 - New use of anti-progestomimetic compounds - Google Patents

New use of anti-progestomimetic compounds

Info

Publication number
AU623805B2
AU623805B2 AU62259/90A AU6225990A AU623805B2 AU 623805 B2 AU623805 B2 AU 623805B2 AU 62259/90 A AU62259/90 A AU 62259/90A AU 6225990 A AU6225990 A AU 6225990A AU 623805 B2 AU623805 B2 AU 623805B2
Authority
AU
Australia
Prior art keywords
progestomimetic
compounds
new use
antiprogestomimetics
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU62259/90A
Other languages
English (en)
Other versions
AU6225990A (en
Inventor
Jean Andre Grandadam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of AU6225990A publication Critical patent/AU6225990A/en
Application granted granted Critical
Publication of AU623805B2 publication Critical patent/AU623805B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62259/90A 1989-09-07 1990-09-07 New use of anti-progestomimetic compounds Ceased AU623805B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8911699 1989-09-07
FR8911699A FR2651435A1 (fr) 1989-09-07 1989-09-07 Nouvelle utilisation de composes anti-progestomimetiques.

Publications (2)

Publication Number Publication Date
AU6225990A AU6225990A (en) 1991-03-14
AU623805B2 true AU623805B2 (en) 1992-05-21

Family

ID=9385212

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62259/90A Ceased AU623805B2 (en) 1989-09-07 1990-09-07 New use of anti-progestomimetic compounds

Country Status (10)

Country Link
US (1) US5173483A (enExample)
EP (1) EP0417003B1 (enExample)
JP (1) JP3032258B2 (enExample)
KR (1) KR0180225B1 (enExample)
AT (1) ATE107859T1 (enExample)
AU (1) AU623805B2 (enExample)
CA (1) CA2024728A1 (enExample)
DE (1) DE69010294T2 (enExample)
DK (1) DK0417003T3 (enExample)
FR (1) FR2651435A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718138B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Nouveaux stéroïdes comportant en position 20 une chaîne aminosubstituée, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les renfermant.
DE69500542T2 (de) * 1994-05-19 1998-01-02 Akzo Nobel Nv 11,21-Bisphenyl-19-nor-pregnan Derivate
DE4434488A1 (de) * 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
ATE194358T1 (de) * 1996-05-01 2000-07-15 Us Gov Health & Human Serv 21-substituierte progesteron derivate als antigestagene
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
ATE376839T1 (de) * 2001-12-21 2007-11-15 Pantarhei Bioscience Bv Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren
EP1613640A4 (en) * 2003-02-28 2010-05-19 Us Gov Health & Human Serv PROCESS FOR PREPARING 17 ALPHA-ACETOXY-11 BETA- (4-N, N-DIMETHYLAMINOPHENYL) -19-NORPREGNA-4,9-DIENE-3,20-DION, INTERMEDIATE PRODUCTS AND METHOD OF MANUFACTURING THESE INTERMEDIATE PRODUCTS
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists
WO2017112909A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
WO2017112904A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
US11124537B2 (en) 2015-12-23 2021-09-21 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
KR20210039001A (ko) 2016-10-07 2021-04-08 오릭 파마슈티칼스, 인크. 글루코코르티코이드 수용체의 억제제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2625505B2 (fr) * 1981-01-09 1991-05-10 Roussel Uclaf Nouveaux derives steroides substitues en 11beta leur procede de preparation et leur application comme medicaments et les compositions pharmaceutiques les renfermant
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
DE3200459A1 (de) * 1982-01-09 1983-07-21 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der azyklie bei schafen oder rindern
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
US4833133A (en) * 1986-05-22 1989-05-23 Sterling Drug Inc. Method of regulating fertility in cattle using epostane
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese

Also Published As

Publication number Publication date
ATE107859T1 (de) 1994-07-15
DE69010294D1 (de) 1994-08-04
DK0417003T3 (da) 1994-07-25
EP0417003A3 (en) 1991-12-04
EP0417003B1 (fr) 1994-06-29
JP3032258B2 (ja) 2000-04-10
FR2651435A1 (fr) 1991-03-08
DE69010294T2 (de) 1994-10-27
JPH0399015A (ja) 1991-04-24
FR2651435B1 (enExample) 1994-04-22
CA2024728A1 (fr) 1991-03-08
US5173483A (en) 1992-12-22
AU6225990A (en) 1991-03-14
EP0417003A2 (fr) 1991-03-13
KR910005873A (ko) 1991-04-27
KR0180225B1 (ko) 1999-03-20

Similar Documents

Publication Publication Date Title
GR78442B (enExample)
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
EP0337256A3 (de) Verfahren zur Herstellung pharmazeutischer Mischungen
HUT68963A (en) Novel 4-arylpiperazines and 4-arylpiperidines, pharmaceutical compositions comprising them and the proces for producing thereof
GR3015513T3 (en) Use of baclofen for the preparation of medicaments for the treatment of angina pectoris.
AU623805B2 (en) New use of anti-progestomimetic compounds
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
AU5992990A (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
ZA929879B (en) Compositions for the treatment of mammalian diseases.
KR950013453B1 (en) Composition containing 15-deoxisper gualine
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
ES2027507A6 (es) Procedimiento de preparacion de derivados selenofenicos.
JO1493B1 (en) Pharmaceutical combination for treating high blood pressure
IT1269740B (it) Derivati di combretastatine ad attivita' anti-tumorale e procedimento per la loro preparazione
IL89431A0 (en) Pharmaceutical compositions for the treatment of autoimmune diseases
IE894219L (en) Pharmaceutical composition for the application of baclofen
AU6975891A (en) Pharmaceutical compositions for the treatment of drug dependence
AU577570B2 (en) Mefloquine quinates
AU625716C (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
HU895333D0 (en) Process for the preparation of pharmaceutical compositions
GR920100421A (el) Τετραυδροβενζοθειενοπυριδινες εχουσα δραση κ.ν.ς.
AU3802689A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired